Vnitr Lek 2012, 58(Suppl 2):16-19

Acute myeloid leukaemia - the post and present of the treatment in the world and the Institute of Heamatology and Blood Transfusion in Prague

P. Soukup*, J. Soukupová Maaloufová, J. Čermák, P. Cetkovský, M. Lukášová
Ústav hematologie a krevní transfuze Praha, ředitel prof. MUDr. Marek Trněný, CSc.

Despite the boom in the field of molecular genetics and genomics, acute myeloid leukemia remains an important challenge. Though patient-tailored treatment results have seen great improvement, we are still behind our and our patients expectations.

Keywords: acute myeloid leukemia; anthracycline; cytosin arabinosid; bone marrow transplantation

Received: May 17, 2012; Published: April 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Soukup P, Soukupová Maaloufová J, Čermák J, Cetkovský P, Lukášová M. Acute myeloid leukaemia - the post and present of the treatment in the world and the Institute of Heamatology and Blood Transfusion in Prague. Vnitr Lek. 2012;58(Supplementum 2):16-19.
Download citation

References

  1. Tallman MS. Acute myeloid leukemia; decided victories, disappointments, and detente: an historical perspective. Hematology Am Soc Hematol Educ Program 2008: 390. Go to original source... Go to PubMed...
  2. Mayer J, Starý J. Historie a poznání léčby leukemií. In: Mayer J, Starý J (eds). Leukemie. Praha: Grada 2002: 19-20.
  3. Freireich EJ. Four decades of therapy for AML. Leukemia 1998; 12 (Suppl 1): S54-S56. Go to PubMed...
  4. Crowther D, Powles RL, Bateman CJ et al. Management of adult acute myelogenous leukemia. Br Med J 1973; 20: 131-137. Go to original source... Go to PubMed...
  5. Thomas ED, Buckner CD, Banaji M et al. One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 1977; 49: 511-533. Go to original source...
  6. Fay JW, Silberman HR, Moore JO et al. Autologous marrow transplantation for patients with acute myelogenous leukemia - a preliminary report. Exp Hematol 1979; 7 (Suppl 5): 302-308. Go to PubMed...
  7. Mayer RJ, Davis RB, Schiffer CA et al. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B. N Engl J Med 1994; 331: 896-903. Go to original source... Go to PubMed...
  8. ASH Annual Meeting and Exposition 2011. Atlanta, USA.
  9. Tallman MS, Altman JK. Curative strategies in acute promyelocytic leukemia. Hematology Am Soc Hematol Educ Program 2008: 391-399. Go to original source... Go to PubMed...
  10. Lukášová M, Sedláčková M, Libánský J et al. Problematika výskytu infekčních komplikací v průběhu léčby akutní leukemie. Vnitř Lék 1979; 25: 542-549. Go to PubMed...
  11. Lukášová M, Chudomel V, Ježková Z et al. První zkušenosti s léčbou akutních leukemií na jednotce intenzivní hematologické péče. Vnitř Lék 1980; 26: 1059-1064. Go to PubMed...
  12. Lukášová M, Sedláčková M, Chudomel V et al. Výsledky léčby nemocných a akutní leukemií na jednotce intenzivní hematologické péče. Prakt Lék 1983; 63: 918-921.




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.